LINDSEY MCCRAY: Open Payments
NPI 1972986586 · CHATTANOOGA, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,072 in 57 payments from 13 companies in 2025. Trend: 2023 $1,852 · 2024 $1,296 · 2025 $1,072
Food & beverage: $1,072
| Company | Payments | Amount |
|---|---|---|
| Supernus Pharmaceuticals, Inc. | 11 | $205 |
| Axsome Therapeutics, Inc. | 12 | $136 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $117 |
| Vanda Pharmaceuticals Inc. | 3 | $100 |
| Otsuka America Pharmaceutical, Inc. | 6 | $96 |
| Lundbeck LLC | 4 | $84 |
| Corium, LLC | 4 | $79 |
| Janssen Pharmaceuticals, Inc | 4 | $78 |
| Neurocrine BioSciences, Inc. | 3 | $60 |
| Teva Pharmaceuticals USA, Inc. | 2 | $47 |
Products named: Qelbree, Auvelity, REXULTI, CAPLYTA, HETLIOZ, Azstarys, SPRAVATO, INGREZZA.
Industry payments across TN — which companies pay providers there.
